Pathophysiology, epidemiology, and impact of migraine

Clinical Cornerstone

Volumn 4, Issue 3, 2001, Pages 1-17

  Mathew, Ninan T ^a  

^a Houston Headache Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; DIHYDROERGOTAMINE; ERGOTAMINE; GUANYLATE CYCLASE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE; PLACEBO; SCAVENGER; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; CACNA1A PROTEIN, HUMAN; CALCIUM CHANNEL; SEX HORMONE;

ARTICLE; BRAIN CORTEX; BRAIN STEM; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ECONOMIC ASPECT; FEMALE; GENETICS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; POPULATION; PREVALENCE; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TENSION HEADACHE; TRIGEMINUS ARTERY; UNITED STATES; WORK DISABILITY; ADOLESCENT; ADULT; AGED; COST OF ILLNESS; ECONOMICS; METABOLISM; MIDDLE AGED; MIGRAINE WITH AURA; REVIEW; TRIGEMINAL NERVE;

ADOLESCENT; ADULT; AGED; BRAIN STEM; CALCIUM CHANNELS; CEREBRAL CORTEX; COST OF ILLNESS; FEMALE; GONADAL STEROID HORMONES; HEADACHE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MIGRAINE WITH AURA; NITRIC OXIDE; PREVALENCE; TRIGEMINAL NERVE; UNITED STATES;

EID: 0035671830     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(01)90035-3     Document Type: Article

References (82)

1. Increased familial risk and evidence of genetic factor in migraine
2. Evidence of a genetic factor in migraine with aura: A population-based Danish twin study
3. Migraine without aura: A population-based twin study
4. Familial hemiplegic migraine in the Netherlands
5. Genetic heterogeneity of familial hemiplegic migraine
6. A gene for familial hemiplegic migraine maps to chromosome 19
7. Mapping of a second locus for familial hemiplegic migraine to 1q 21-q 23 and evidence of further heterogeneity
8. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4
9. Delayed cerebral edema and fatal coma after minor head trauma: Role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine
10. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetic Research Group
11. Familial hemiplegic migraine locus on 19p13 is involved in human forms of migraine with and without aura
12. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura
13. Neuromuscular transmission in migraine: A single-fiber EMG study in clinical subgroups
14. A quantified finger-nose test indicates subclinical cerebellar signs in a subgroup of migraine patients
15. Recent advances in the molecular understanding of voltage-gated Ca(2+) channels
16. The concept of migraine as a state of central neuronal hyper-excitability
17. Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks
18. Auditory event-related potential in migraine
19. Interictal potentiate of passive "oddball" auditory event-related potentials in migraine
20. Pathophysiology of migraine aura: The spreading depression theory
21. Spreading depression of activity in cerebral cortex
22. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine
23. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache
24. SPECT demonstration of delayed hyperemia following hypoperfusion in classic migraine
25. Regional cerebral blood flow and oxygen metabolism during migraine with and without aura
26. Perfusion-weighted imaging defects during spontaneous migraine aura
27. Cerebral oxygen extraction, oxygen consumption and regional cerebral blood flow during aura phase of migraine
28. Functional MRI (fMRI) of visually triggered headache. Activation, suppression and propagation of "bold" effect
29. Vasoactive peptide release in extracerebral circulation of humans during migraine headache
30. Brain stem activation in spontaneous human migraine attacks
31. Effect on trigeminal firing of PQ-type calcium channels in the periaqueductal grey
32. Neuropeptide localization in the "migraine generator" region of the human brainstem
33. Periaqueductal grey matter dysfunction in migraine: Cause or burden of illness?
34. Headache may arise from perturbation of brain
35. 3H-dihydroergotamine binding sites in the cat central nervous system: Relevance to migraine
36. Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation
37. Periaqueductal grey matter modulates trigeminal vascular input: A role in migraine
38. Brain stem activations specific to migraine headache
39. The trigeminal vascular system in humans: Pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation
40. Inhibitory influence of GABA on central serotonergic transmission. Raphe nuclei as the neuroanatomical site of GABA-ergic inhibition of cerebral serotonergic neurons
41. Drug-induced refractory headache: Clinical features and management
42. Cervicalgia in migraine: Prevalence, clinical characteristics and response for treatment
43. On serotonin and migraine: A clinical and pharmacological review
44. Synthesis of migraine mechanisms
45. Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat
46. Neocortical spreading depression provokes the expression of c-Fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms
47. Basic mechanisms in vascular headache
48. An association between migraine and cutaneous allodynia
49. Current concepts of the pathophysiology of migraine
50. Mode of action of the anti-migraine drug sumatriptan
51. The role of estradiol withdrawal in the etiology of menstrual migraine
52. Intravenous nitroglycerin as an experimental model of vascular headache: Basic characteristics
53. Cluster headache: Transcranial Doppler ultrasound and rCBF studies
54. Extracranial vascular response to sublingual nitroglycerin and oxygen inhalation in cluster headache patients
55. Nitric oxide-induced headache in patients with chronic tension-type headache
56. Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain
57. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks
58. Effect of a nitric oxide donor on nitroxergic nerve fibers in the rat dura mater
59. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
60. SB220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anesthetized cat
61. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan
62. Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine mechanism for sumatriptan
63. Nitroglycerin infusion causes a delayed inflammatory response in rat duramater
64. The effect of nitric oxide and nitric oxide synthase inhibitors on rat dural meningeal vessels
65. Nitric oxide in primary headaches
66. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanisms of modulation by high and low oxygen tension
67. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries
68. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME
69. Nitric oxide synthase inhibitor in migraine
70. Effect of inhibition of nitric oxide synthase in chronic tension-type headache: A randomized crossover trial
71. Prevalence of migraine headache in the United States in relation to age, income, race and other sociodemographic factors
72. Epidemiology of headache in Germany: A nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society
73. A nationwide survey of migraine in France: Prevalence and clinical features in adults
74. Epidemiology of headache
75. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
76. Classification and diagnostic criteria for headache disorders, cranial neurosurgery and facial pain
77. Prevalence of frequent headache in a population sample
78. Epidemiology of chronic daily headache in the general population
79. Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up
80. Prevalence and description of chronic daily headache in the general population in France in 2000
81. Impact of migraine in the United States: Data from national health interview survey
82. Health care resource and lost labor: Cost of migraine headache in the United States